Skip to main content

A single arm, prospective, open label, multicentre study for evaluation of efficacy and safety of IV CERA for treatment of chronic renal anaemia in dialysis patients not currently treated with ESA.

Author
Abstract
:

CERA, a continuous erythropoietin receptor activator, has reported effective correction of anaemia in international clinical trials.

Year of Publication
:
2014
Journal
:
The Journal of the Association of Physicians of India
Volume
:
62
Issue
:
3
Number of Pages
:
232-6
ISSN Number
:
0004-5772
Short Title
:
J Assoc Physicians India
Download citation